Opening European eHealth research programmes to new participants

As Europe's population ages, improving healthcare and inclusion for the elderly is becoming a fast expanding field of research. But researchers in the new member states and candidate countries have been slow to take advantage of IST funding and cooperation in these areas. The EPIST project team sought to change that.

"The main problem is that research organisations and companies in the New Member Countries (NMCs) and Associated Candidate Countries (ACCs) don't know how EU research projects work," explains EPIST coordinator Ira Vater of European Business Associates in Italy.

"They don't know where to obtain information about research programmes, they don't know how to go about forming a consortium," he continues. "And even if a company or research institute in an NMC or ACC comes up with the idea, they very rarely become coordinators of the project because they lack the experience of managing these kinds of research initiatives."

EPIST, which ended in September 2006 after 18 months of work, focused on helping researchers in ten Eastern European and Mediterranean countries (which joined the Union in 2004) and three candidate countries (Bulgaria, Romania and Turkey) navigate the European Union's IST programme in the fields of e-health and e-inclusion.

Helping find projects and partners
The EPIST team developed a database and partner search tool (that is available for free on the internet) to help researchers "get their foot in the door" of EU-funded research, regardless of their location in Europe. The team also held a series of workshops in new member states and accession countries to train research organisations and companies to build consortia and obtain European financing for projects. Meanwhile, international brokerage events brought researchers from different countries together to share ideas and build partnerships.

"More than 400 organisations from both new and old member states have added themselves to our database, while we have 690 subscribers to our quarterly newsletter," Vater explains.

She says the EPIST team has been particularly surprised by the interest the project elicited not just in the NMCs and ACCs but also in the EU's fifteen established member countries.

"Though we concentrated on making ourselves and the benefits of our services known in the new member states and candidate countries, we also found that a lot of organisations from older member states wanted to participate," she says. "This is particularly important in order to bridge the research gaps that exist in Europe."

In-depth surveys of the status of e-health and e-inclusion activities in the NMCs and ACCs, which included reviews of national research programs and sources of funding, gave the project team a clear idea of the needs of researchers in different states. The surveys have also revealed the potential for greater cross-border collaboration.

"Some of the NMCs are very advanced in their development and implementation of e-health and e-inclusion technologies," Vater explains. "But researchers are not accustomed to the European system of research programmes."

The 16 workshops the EPIST team held in 2005 and 2006 provided researchers from NMCs and ACCs with crucial knowledge about the IST research programme. Representatives of around 25 research organisations and companies participated in each event. Three brokerage meetings meanwhile brought together researchers and organisations from both old and new members.

Importance of e-health and e-inclusion
The project concentrated on the fields of e-health and e-inclusion because they are becoming increasingly important areas of European research, Vater says. They will continue to be so for the foreseeable future as Europe’s population ages, requiring new technologies to maintain or improve healthcare standards and to ensure the elderly and disabled are not excluded from society.

"It is about helping everybody benefit from the information society," Vater explains. She notes that the EPIST team's approach to fomenting collaboration among organisations across Europe could be applied to other fields of research as well.

The project ended in September 2006. However Vater says that the consortium plans to continue its work and maintain the website and database, as well as continuing to publish newsletters for the foreseeable future. They are also planning to launch a follow-up project that could lead to the research database and partner-search solutions being deployed commercially.

Contact:
Ira Vater
EBA European Business Associates
Srl Via Gregorio VII, 186
I-00165 Rome
Italy
Tel: +39 06 9761 6717
Fax: +39 06 3937 7588
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Source: IST Results Portal

For further information, please visit:
http://www.epist.org

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...